TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research May 14, 1993
TCL Archive In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas January 1, 1993